Abstract
Frailty status is a condition which is not merely induced by aging but mainly by a progressive and sustained deterioration of several body physiological processes that lead to an increased vulnerability to stressors. The prevalence of frailty is higher in older individuals with chronic kidney disease (CKD) compared to older people with normal renal function. Frailty prevalence increases with a worsened kidney function, which leads to an increase in falls, hospitalization, dialysis requirement, and mortality. CKD predisposes to frailty through many mechanisms, which can also lead to CKD progression. The coexistence of CKD and frailty phenotype has been considered a particular condition known as “senescent nephropathy,” since it is characterized by significant clinical complications, therapeutic demands, and worse prognosis, in comparison with robust older CKD patients. Frailty status trends should be identified since they represent an opportunity to successfully intervene by optimizing nutritional and rehabilitation efforts. The prevention or delay of the appearance of frailty and sarcopenia can be accomplished by low intensity resistance and aerobic physical exercise, caloric and protein intake, vitamin D supplementation, and avoidance of polypharmacy. In addition, these patients should also receive their corresponding CKD treatment, but even frailty evaluation can contribute to redesign the patient’s therapeutic objectives.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nixon AC, Bampouras TM, Pendleton N, Mitra S, Dhaygude AP. Diagnostic accuracy of frailty screening methods in advanced chronic kidney disease. Nephron. 2019;141(3):147–55. https://doi.org/10.1159/000494223.
Coppolino G, Bolignano D, Gareri P, Ruberto C, Andreucci M, Ruotolo G, Rocca M, Castagna A. Kidney function and cognitive decline in frail elderly: two faces of the same coin? Int Urol Nephrol. 2018;50(8):1505–10. https://doi.org/10.1007/s11255-018-1900-3.
Ali H, Abdelaal F, Baharani J. Assessment of frailty in elderly pre-dialysis population using simple tools. Saudi J Kidney Dis Transpl. 2017;28(4):716–24.
Ostuni M, Musso CG. Usefulness of frailty evaluation for handling chronic kidney disease elderly patients: a review and original proposal. Int Urol Nephrol. 2019;51(3):461–5. https://doi.org/10.1007/s11255-018-2061-0.
Demircioglu DT. The Association of Vitamin D levels and the frailty phenotype among non-geriatric dialysis patients: a cross-sectional study. Clinics (Sao Paulo). 2018;73:e116. https://doi.org/10.6061/clinics/2018/e116.
Musso CG, Vilas M, Onuigbo M. Nephroprevention in the oldest old with chronic kidney disease: special considerations. World J Nephrol. 2015;4(1):1–5. https://doi.org/10.5527/wjn.v4.i1.1.
Adame Perez SI, Senior PA, Field CJ, Jindal K, Mager DR. Frailty, health-related quality of life, cognition, depression, vitamin D and health-care utilization in an ambulatory adult population with type 1 or type 2 diabetes mellitus and chronic kidney disease: a cross-sectional analysis. Can J Diabetes. 2019;43(2):90–7. https://doi.org/10.1016/j.jcjd.2018.06.001.
Bohm CJ, Storsley LJ, Hiebert BM, Nelko S, Tangri N, Cheskin LJ, McAdams-DeMarco MA, Rigatto C. Impact of exercise counseling on physical function in chronic kidney disease: an observational study. Can J Kidney Health Dis. 2018;5:2054358117753615. https://doi.org/10.1177/2054358117753615.
Van Pilsum Rasmussen S, Konel J, Warsame F, Ying H, Buta B, Haugen C, King E, DiBrito S, Varadhan R, Rodríguez-Mañas L, Walston JD, Segev DL, McAdams-DeMarco M. Engaging clinicians and patients to assess and improve frailty measurement in adults with end stage renal disease. BMC Nephrol. 2018;19(1):8. https://doi.org/10.1186/s12882-017-0806-0.
Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol. 2015;47(11):1801–7. https://doi.org/10.1007/s11255-015-1112-z.
McAdams-DeMarco MA, Ying H, Thomas AG, Warsame F, Shaffer AA, Haugen C, Garonzik-Wang JM, Desai NM, Varadhan R, Walston J, Norman SP, Segev DL. Frailty, inflammatory markers, and waitlist mortality among patients with end-stage renal disease in a prospective cohort study. Transplantation. 2018;102(10):1740–6. https://doi.org/10.1097/TP.0000000000002213.
Nixon AC, Bampouras TM, Pendleton N, Woywodt A, Mitra S, Dhaygude A. Frailty and chronic kidney disease: current evidence and continuing uncertainties. Clin Kidney J. 2018;11(2):236–45. https://doi.org/10.1093/ckj/sfx134.
Kittiskulnam P, Sheshadri A, Johansen K. Consequences of CKD on functioning. Semin Nephrol. 2016;36(4):305–18. https://doi.org/10.1016/j.semnephrol.2016.05.007.
Kamijo, Kanda E, Ishibashi Y, Yoshida M. Sarcopenia and frailty in PD: impact on mortality, malnutrition, and inflammation. Perit Dial Int. 2018;38(6):447–54. https://doi.org/10.3747/pdi.2017.00271.
McAdams-DeMarco MA, Ying H, Olorundare I, King EA, Desai N, Dagher N, Lonze B, Montgomery R, Walston J, Segev DL. Frailty and health-related quality of life in end stage renal disease patients of all ages. J Frailty Aging. 2016;5(3):174–9.
Musso CG, Trigka K, Dousdampanis P, Jauregui J. Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature. Int Urol Nephrol. 2015;47(4):647–54. https://doi.org/10.1007/s11255-014-0886-8.
Ortiz A, Sanchez-niño M. Sarcopenia in CKD: a roadmap from basic pathogenetic mechanisms to clinical trials. Clin Kidney J. 2019;12(1):110–2.
Sieverdes JC, Rao V, Taber DJ, Noltemeyer Z, McGillicuddy JW, Bergamin M, Thangavel S, Baliga PK. Feasibility and functional testing for frailty in chronic kidney disease. Prog Transplant. 2018;28(3):299–300. https://doi.org/10.1177/1526924818781577.
Moffatt H, Moorhouse P, Mallery L, Landry D, Tennankore K. Using the Frailty Assessment for Care Planning Tool (FACT) to screen elderly chronic kidney disease patients for frailty: the nurse experience. Clin Interv Aging. 2018;13:843–52. https://doi.org/10.2147/CIA.S150673.
Wawer AA, Jennings A, Fairweather-Tait SJ. Iron status in the elderly: a review of recent evidence. Mech Ageing Dev. 2018;175:55–73. https://doi.org/10.1016/j.mad.2018.07.003.
Formica M, Politano P, Marazzi F, Tamagnone M, Serra I, Marengo M, Falconi D, Gherzi M, Tattoli F, Bottaro C, Giuliano D, Tibaldi V, Isaia GC. Acute kidney injury and chronic kidney disease in the elderly and polypharmacy. Blood Purif. 2018;46(4):332–6. https://doi.org/10.1159/000492149.
Bansal AD, Leonberg-Yoo A, Schell JO, Scherer JS, Jones CA. Ten tips nephrologists wish the palliative care team knew about caring for patients with kidney disease. J Palliat Med. 2018;21(4):546–51. https://doi.org/10.1089/jpm.2018.0087.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Colombo, M., Musso-Enz, V.P., Romero, M.d.P., Aroca-Martinez, G., Musso, C.G. (2021). Frailty in Non-Dialysis ChronicKidney Disease. In: Musso, C.G., Jauregui, J.R., Macías-Núñez, J.F., Covic, A. (eds) Frailty and Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-53529-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-53529-2_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-53528-5
Online ISBN: 978-3-030-53529-2
eBook Packages: MedicineMedicine (R0)